ArticleHepatology (Baltimore, Md.)2017

Aspirin for cholangiocarcinoma prevention: New targets to shift the dogma from ascertained risk to possible prevention.

Giovanni Brandi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.